Home・Aktien・Baxter International Inc

Baxter International Inc

Geschlossen

BrancheGesundheitswesen

26.72 -1.44

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

26.58

Max

27.09

Schlüsselkennzahlen
By Trading Economics
Einkommen	141M 126M
Verkäufe	259M 3B
EPS	0.56
Dividendenrendite	0.73
Gewinnspanne	4.257
Angestellte	37,500
EBITDA	177M 474M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-3.11% downside

Dividenden
By Acuity
Dividendenrendite Branchendurchschnitt	0.73% 2.22%
Nächstes Ergebnis	29. Okt. 2026
Nächste Dividendenausschüttung	1. Okt. 2026
Nächstes Ex-Dividendendatum	28. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	2.3B 14B
Vorheriger Eröffnungskurs	28.16
Vorheriger Schlusskurs	26.72

Nachrichtenstimmung

By Acuity

29%

71%

104 / 340 Ranking in Healthcare

Baxter International Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

Baxter International Inc Prognose

Kursziel

By TipRanks

-3.11% Nachteil

12-Monats-Prognose

Durchschnitt 25.9 USD -3.11%

Hoch 29 USD

Tief 21 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Baxter International Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

10 ratings

Buy

Halten

Sell

Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Baxter International Inc – Dist abgegeben haben.

Stimmung

By Acuity

104 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.